The MBRS SCORE program at Texas A&M University-Kingsville consists of the following primary objectives: (1) establish and provide support for an appropriate biomedical research environment at TAMUK; (2) provide a suitable infrastructure that permits participant investigators to examine key aspects of biomedical research; and (3) provide substantial and significant data and information regarding questions of biomedical relevance and importance. ? ? The four currently funded projects encompass apoptosis, neurogenetics, venom disintegrin action, and optic nerve regeneration. The eight supplemental projects described in this proposal encompass novel drug design approaches, nutritional status and bone density loss, leptin signaling in the nervous system, West Nile Virus transmission, emerging zoonotic diseases, maternal-affected stress responses, natural products derived from citrus plants, and reproductive-somatotropic interactions. ? ? Together these eight new projects, in addition to the four currently funded projects, will support research in five different departments and provide ideal opportunities for the participant faculty to expand and enhance their individual research programs. The research goals of the individual investigators will also provide excellent opportunities for the training of undergraduate and graduate students in key aspects of biomedical research as well as suitable preparation for future careers in biomedical research. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Minority Biomedical Research Support - MBRS (S06)
Project #
3S06GM008107-29S1
Application #
6810255
Study Section
Minority Programs Review Committee (MPRC)
Program Officer
Gaillard, Shawn R
Project Start
1997-03-01
Project End
2007-01-31
Budget Start
2004-09-01
Budget End
2005-01-31
Support Year
29
Fiscal Year
2004
Total Cost
$66,764
Indirect Cost
Name
Texas A&M University-Kingsville
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
868154089
City
Kingsville
State
TX
Country
United States
Zip Code
78363
Zwink, Nadine; Jenetzky, Ekkehart (2018) Maternal drug use and the risk of anorectal malformations: systematic review and meta-analysis. Orphanet J Rare Dis 13:75
Garcia, Michelle R (2017) Leptin Contributes to the Development of the Corpus Luteum. Cell Dev Biol 6:
Wiles, Jessica R; Katchko, Robin A; Benavides, Elizabeth A et al. (2014) The effect of leptin on luteal angiogenic factors during the luteal phase of the estrous cycle in goats. Anim Reprod Sci 148:121-9
Saisawat, Pawaree; Kohl, Stefan; Hilger, Alina C et al. (2014) Whole-exome resequencing reveals recessive mutations in TRAP1 in individuals with CAKUT and VACTERL association. Kidney Int 85:1310-7
Bartels, Enrika; Schulz, Anna C; Mora, Nicole W et al. (2012) VATER/VACTERL association: identification of seven new twin pairs, a systematic review of the literature, and a classical twin analysis. Clin Dysmorphol 21:191-5
Pathi, Satya S; Jose, Soumia; Govindaraju, Suman et al. (2012) zRICH, a protein induced during optic nerve regeneration in zebrafish, promotes neuritogenesis and interacts with tubulin. Brain Res 1474:29-39
Collier, C T; Williams, P N; Carroll, J A et al. (2011) Effect of maternal restraint stress during gestation on temporal lipopolysaccharide-induced neuroendocrine and immune responses of progeny. Domest Anim Endocrinol 40:40-50
Weber, Stefanie; Thiele, Holger; Mir, Sevgi et al. (2011) Muscarinic Acetylcholine Receptor M3 Mutation Causes Urinary Bladder Disease and a Prune-Belly-like Syndrome. Am J Hum Genet 89:668-74
Sanchez, Elda E; Rodriguez-Acosta, Alexis; Palomar, Rene et al. (2009) Colombistatin: a disintegrin isolated from the venom of the South American snake (Bothrops colombiensis) that effectively inhibits platelet aggregation and SK-Mel-28 cell adhesion. Arch Toxicol 83:271-9
Salazar, Ana Maria; Guerrero, Belsy; Cantu, Bruno et al. (2009) Venom variation in hemostasis of the southern Pacific rattlesnake (Crotalus oreganus helleri): isolation of hellerase. Comp Biochem Physiol C Toxicol Pharmacol 149:307-16

Showing the most recent 10 out of 28 publications